Analyst Price Targets — RCEL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 16, 2026 1:35 pm | — | Lake Street | $3.50 | $3.60 | TheFly | Avita Medical price target raised to $3.50 from $3 at Lake Street |
| October 17, 2025 11:38 am | Frank Takkinen | Lake Street | $4.00 | $5.38 | TheFly | Avita Medical downgraded to Hold from Buy at Lake Street |
| January 8, 2025 2:00 pm | Brooks O'Neil | Lake Street | $14.00 | $14.06 | TheFly | Avita Medical price target lowered to $14 from $20 at Lake Street |
| May 14, 2024 3:04 am | Matt O'Brien | Piper Sandler | $9.00 | $8.35 | StreetInsider | Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral |
Latest News for RCEL
The consensus price target hints at a 29.9% upside potential for Avita Medical (RCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, today announced Cary Vance, Interim CEO, and David O'Toole, CFO, will be participating in the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA.
Avita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript
VALENCIA, Calif. , Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Cary Vance, Interim Chief Executive Officer, and David O'Toole, Chief Financial Officer, on February 18, 2026, at 2:00 p.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RCEL.
U.S. House Trading
No House trades found for RCEL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.